Acasti Pharma Inc.

NASDAQ: ACST · Real-Time Price · USD
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 10:00 PM

Acasti Pharma Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 11K 52.16M 15.59M
Gross Profit
n/a -11K -52.16M -15.59M
Operating Income
n/a -11.31M -24.61M -15.59M
Interest Income
n/a n/a 246K 77K
Pretax Income
-12.77M -14.69M -51.97M -10.47M
Net Income
-12.77M -12.85M -42.43M -9.82M
Selling & General & Admin
7.17M 6.18M 6.95M 9.78M
Research & Development
9.51M 4.63M 9.97M 5.56M
Other Expenses
n/a n/a 63K n/a
Operating Expenses
16.68M 11.3M 18.25M 15.34M
Interest Expense
n/a 911K 67.69M 224K
Selling & Marketing Expenses
n/a 341.34K 136K -518K
Cost & Expenses
n/a 11.31M 18.25M 13.18M
Income Tax Expense
n/a -1.78M -9.54M -648K
Shares Outstanding (Basic)
12.09M 9.53M 7.43M 6.14M
Shares Outstanding (Diluted)
12.09M 9.53M 7.43M 6.14M
EPS (Basic)
-0.79 -1.35 -5.71 -1.6
EPS (Diluted)
-0.79 -1.35 -5.71 -1.6
EBITDA
n/a -14.62M 15.85M -19.99M
EBIT
n/a -14.63M -2.55M -9.83M
Depreciation & Amortization
n/a 11K 124K 1.16M